PubMed

Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial.

Schweizer A, Dejager S, Bosi E.

Diabetes Obes Metab. 2009 Aug;11(8):804-12. Epub 2009 May 19.PMID: 19476473 [PubMed - in process]Related articles

How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey.

Mosnier-Pudar H, Hochberg G, Eschwege E, Virally ML, Halimi S, Guillausseau PJ, Peixoto O, Touboul C, Dubois C, Dejager S.

Diabetes Metab. 2009 Jun;35(3):220-7. Epub 2009 Mar 19.PMID: 19303338 [PubMed - indexed for MEDLINE]Related articles

Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes.

Ahrén B, Schweizer A, Dejager S, Dunning BE, Nilsson PM, Persson M, Foley JE.

J Clin Endocrinol Metab. 2009 Apr;94(4):1236-43. Epub 2009 Jan 27.PMID: 19174497 [PubMed - indexed for MEDLINE]Related articles

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.

Ferrannini E, Fonseca V, Zinman B, Matthews D, Ahrén B, Byiers S, Shao Q, Dejager S.

Diabetes Obes Metab. 2009 Feb;11(2):157-66.PMID: 19125777 [PubMed - indexed for MEDLINE]Related articles

Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet.

Halimi S, Schweizer A, Minic B, Foley J, Dejager S.

Vasc Health Risk Manag. 2008;4(3):481-92. Review.PMID: 18827867 [PubMed - indexed for MEDLINE]Related articlesFree article

Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy.

Couvert P, Giral P, Dejager S, Gu J, Huby T, Chapman MJ, Bruckert E, Carrié A.

Pharmacogenomics. 2008 Sep;9(9):1217-27.PMID: 18781850 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of vildagliptin monotherapy during 2-year treatment of drug-naïve patients with type 2 diabetes: comparison with metformin.

Göke B, Hershon K, Kerr D, Calle Pascual A, Schweizer A, Foley J, Shao Q, Dejager S.

Horm Metab Res. 2008 Dec;40(12):892-5. Epub 2008 Aug 22.PMID: 18726829 [PubMed - indexed for MEDLINE]Related articles

Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitus.

Fonseca V, Baron M, Shao Q, Dejager S.

Horm Metab Res. 2008 Jun;40(6):427-30. Epub 2008 Mar 11. No abstract available. PMID: 18401832 [PubMed - indexed for MEDLINE]Related articles

Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database.

Pratley RE, Schweizer A, Rosenstock J, Foley JE, Banerji MA, Pi-Sunyer FX, Mills D, Dejager S.

Diabetes Obes Metab. 2008 Sep;10(10):931-8. Epub 2007 Dec 17.PMID: 18093207 [PubMed - indexed for MEDLINE]Related articles

Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy.

Pratley RE, Rosenstock J, Pi-Sunyer FX, Banerji MA, Schweizer A, Couturier A, Dejager S.

Diabetes Care. 2007 Dec;30(12):3017-22. Epub 2007 Sep 18.PMID: 17878242 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison between vildagliptin and metformin to sustain reductions in HbA(1c) over 1 year in drug-naïve patients with Type 2 diabetes.

Schweizer A, Couturier A, Foley JE, Dejager S.

Diabet Med. 2007 Sep;24(9):955-61. Epub 2007 May 17.PMID: 17509069 [PubMed - indexed for MEDLINE]Related articles

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes.

Fonseca V, Schweizer A, Albrecht D, Baron MA, Chang I, Dejager S.

Diabetologia. 2007 Jun;50(6):1148-55. Epub 2007 Mar 27.PMID: 17387446 [PubMed - indexed for MEDLINE]Related articles

Vildagliptin in drug-naïve patients with type 2 diabetes: a 24-week, double-blind, randomized, placebo-controlled, multiple-dose study.

Dejager S, Razac S, Foley JE, Schweizer A.

Horm Metab Res. 2007 Mar;39(3):218-23.PMID: 17373638 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes.

Rosenstock J, Kim SW, Baron MA, Camisasca RP, Cressier F, Couturier A, Dejager S.

Diabetes Obes Metab. 2007 Mar;9(2):175-85.PMID: 17300593 [PubMed - indexed for MEDLINE]Related articles

Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study.

Garber AJ, Schweizer A, Baron MA, Rochotte E, Dejager S.

Diabetes Obes Metab. 2007 Mar;9(2):166-74.PMID: 17300592 [PubMed - indexed for MEDLINE]Related articles

Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial.

Rosenstock J, Baron MA, Dejager S, Mills D, Schweizer A.

Diabetes Care. 2007 Feb;30(2):217-23. Erratum in: Diabetes Care. 2007 May;30(5):1330. PMID: 17259484 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes.

Pi-Sunyer FX, Schweizer A, Mills D, Dejager S.

Diabetes Res Clin Pract. 2007 Apr;76(1):132-8. Epub 2007 Jan 12.PMID: 17223217 [PubMed - indexed for MEDLINE]Related articles

Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey.

Farnier M, Garnier P, Yau C, Dejager S, Verpilleux MP.

Int J Clin Pract. 2006 Oct;60(10):1166-71. Epub 2006 Aug 24.PMID: 16942588 [PubMed - indexed for MEDLINE]Related articles

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.

Bruckert E, Hayem G, Dejager S, Yau C, Bégaud B.

Cardiovasc Drugs Ther. 2005 Dec;19(6):403-14.PMID: 16453090 [PubMed - indexed for MEDLINE]Related articles

Comparison of efficacy and safety assessment of fluvastatin in patients <65 years versus > or =65 years of age.

Bruckert E, Verpilleux MP, Dejager S, Isaacsohn J.

Am J Cardiol. 2005 Oct 15;96(8):1142-8. Epub 2005 Aug 30.PMID: 16214453 [PubMed - indexed for MEDLINE]Related articles

[The PACIFIQUE registry in post PCI patients: study protocol]

Dubois C, Dejager S, Danchin N.

Ann Cardiol Angeiol (Paris). 2004 Nov;53(6):349-56. French. PMID: 15603178 [PubMed - indexed for MEDLINE]Related articles

Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study.

Wémeau JL, Caron P, Beckers A, Rohmer V, Orgiazzi J, Borson-Chazot F, Nocaudie M, Perimenis P, Bisot-Locard S, Bourdeix I, Dejager S.

J Clin Endocrinol Metab. 2005 Feb;90(2):841-8. Epub 2004 Nov 23.PMID: 15562016 [PubMed - indexed for MEDLINE]Related articlesFree article

A comprehensive description of muscle symptoms associated with lipid-lowering drugs.

Franc S, Dejager S, Bruckert E, Chauvenet M, Giral P, Turpin G.

Cardiovasc Drugs Ther. 2003 Sep-Nov;17(5-6):459-65.PMID: 15107601 [PubMed - indexed for MEDLINE]Related articles

Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil).

Farnier M, Salko T, Isaacsohn JL, Troendle AJ, Dejager S, Gonasun L.

Am J Cardiol. 2003 Oct 1;92(7):794-7.PMID: 14516878 [PubMed - indexed for MEDLINE]Related articles

Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients.

Bruckert E, Lièvre M, Giral P, Crepaldi G, Masana L, Vrolix M, Leitersdorf E, Dejager S.

Am J Geriatr Cardiol. 2003 Jul-Aug;12(4):225-31.PMID: 12888702 [PubMed - indexed for MEDLINE]Related articles

A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length.

Dejager S, Bry-Gauillard H, Bruckert E, Eymard B, Salachas F, LeGuern E, Tardieu S, Chadarevian R, Giral P, Turpin G.

J Clin Endocrinol Metab. 2002 Aug;87(8):3893-901.PMID: 12161529 [PubMed - indexed for MEDLINE]Related articlesFree article

Time course of GH and IGF-1 levels following withdrawal of long-acting octreotide in acromegaly.

Lorcy Y, Dejager S, Chanson P; French Octreotide LAR Group.

Pituitary. 2000 Nov;3(3):193-7.PMID: 11383486 [PubMed - indexed for MEDLINE]Related articles

Smaller LDL particle size in women with polycystic ovary syndrome compared to controls.

Dejager S, Pichard C, Giral P, Bruckert E, Federspield MC, Beucler I, Turpin G.

Clin Endocrinol (Oxf). 2001 Apr;54(4):455-62.PMID: 11318780 [PubMed - indexed for MEDLINE]Related articles

Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia. French Fluvastatin Study Group.

Farnier M, Dejager S.

Am J Cardiol. 2000 Jan 1;85(1):53-7.PMID: 11078237 [PubMed - indexed for MEDLINE]Related articles

Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold value.

Chadarevian R, Bruckert E, Dejager S, Presberg P, Turpin G.

Thromb Res. 1999 Nov 1;96(3):175-82.PMID: 10588459 [PubMed - indexed for MEDLINE]Related articles

[Severe hypercorticism due to opiate withdrawal]

Dejager S, Foubert L, Turpin G.

Presse Med. 1998 May 23-30;27(19):912-3. French. No abstract available. PMID: 9767854 [PubMed - indexed for MEDLINE]Related articles

Sheehan's syndrome: differential diagnosis in the acute phase.

Dejager S, Gerber S, Foubert L, Turpin G.

J Intern Med. 1998 Sep;244(3):261-6. Review.PMID: 9747750 [PubMed - indexed for MEDLINE]Related articles

[Adrenal incidentalomas disclosing enzyme block in a 66-year-old man]

Turpin G, Jullien V, Dejager S, Chadarevian R, Foubert L.

Presse Med. 1997 Jan 18-25;26(1):16. French. No abstract available. PMID: 9082397 [PubMed - indexed for MEDLINE]Related articles

[Lipid risk factors of atherosclerosis: who, when, how to treat?]

Foubert L, Dejager S, Bruckert E, Turpin G.

Ann Endocrinol (Paris). 1997;58(4):275-82. French. PMID: 9436473 [PubMed - indexed for MEDLINE]Related articles

[Hyperlipidemia in pregnancy]

Dejager S, Turpin G.

Presse Med. 1996 Nov 30;25(37):1839-45. Review. French. PMID: 8991039 [PubMed - indexed for MEDLINE]Related articles

[Atherogenicity of low-density lipoproteins (LDL). A problem of quantity or quality?]

Dejager S, Turpin G.

Presse Med. 1995 Dec 9;24(38):1772-6. Review. French. PMID: 8545426 [PubMed - indexed for MEDLINE]Related articles

[Acute hyponatremia after resection of a pituitary micro-adenoma by transphenoidal approach]

Turpin G, Foubert L, Pichard C, Dejager S, Bruckert E.

Presse Med. 1995 Apr 15-22;24(15):736. French. No abstract available. PMID: 7784411 [PubMed - indexed for MEDLINE]Related articles

[Lipoprotein lipase: a key enzyme of lipid metabolism]

Bruckert E, Dejager S.

Rev Prat. 1994 Jun 1;44(11):1487-93. Review. French. PMID: 7939219 [PubMed - indexed for MEDLINE]Related articles

Dominant negative mutations of the scavenger receptor. Native receptor inactivation by expression of truncated variants.

Dejager S, Mietus-Snyder M, Friera A, Pitas RE.

J Clin Invest. 1993 Aug;92(2):894-902.PMID: 8349824 [PubMed - indexed for MEDLINE]Related articlesFree article

Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia.

Bruckert E, Dejager S, Chapman MJ.

Atherosclerosis. 1993 Apr;100(1):91-102. Erratum in: Atherosclerosis 1993 Aug;102(1):129. PMID: 8318067 [PubMed - indexed for MEDLINE]Related articles

Oxidized low density lipoproteins bind to the scavenger receptor expressed by rabbit smooth muscle cells and macrophages.

Dejager S, Mietus-Synder M, Pitas RE.

Arterioscler Thromb. 1993 Mar;13(3):371-8.PMID: 7680228 [PubMed - indexed for MEDLINE]Related articlesFree article

Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.

Dejager S, Bruckert E, Chapman MJ.

J Lipid Res. 1993 Feb;34(2):295-308.PMID: 8429263 [PubMed - indexed for MEDLINE]Related articlesFree article

Further characterization of the acetyl LDL (scavenger) receptor expressed by rabbit smooth muscle cells and fibroblasts.

Pitas RE, Friera A, McGuire J, Dejager S.

Arterioscler Thromb. 1992 Nov;12(11):1235-44.PMID: 1420082 [PubMed - indexed for MEDLINE]Related articlesFree article

[Impotence: therapeutic possibilities]

Dejager S, Thomas M.

Ann Med Interne (Paris). 1990;141(4):367-73. Review. French. No abstract available. PMID: 2240949 [PubMed - indexed for MEDLINE]Related articles

[Low density lipoprotein (LDL) heterogeneity and atherosclerosis]

Dejager S, Cohen R, Bruckert E.

Ann Biol Clin (Paris). 1990;48(3):154-60. Review. French. PMID: 2191608 [PubMed - indexed for MEDLINE]Related articles